Medical Affairs and Scientific Communications Forum

3 Meetings, 1 Location: Medical Communications, Medical Science Liaisons, Medical Writing

戻る Agenda

Session 9 Track 2: Automation Technologies in Medical Writing

Session Chair(s)

Ruggero Galici, PhD

Director, Nonclinical and Clinical Pharmacology Writing

Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States

Automation technologies, especially when combined with artificial intelligence, are disrupting many sectors including the healthcare. This session will explore challenges and opportunities of automation technologies in medical writing. Few examples of how companies and the FDA are using or plan to use automation technologies to improve efficiencies will be discussed.

Learning Objective : At the conclusion of this session, participants should be able to:
Identify potential automation technologies in medical writing
Recognize challenges and opportunities when implementing automation technologies in medical writing

Speaker(s)

Automation and AI in Medical Writing: Pie in the Sky or a Paradigm Shift?

Sian Ratcliffe, PhD

Pfizer Inc, United States

Vice President, Head of Medical Writing

AI in the Medical Writing Landscape – Tales from a Pilot Project

Julia Forjanic-Klapproth, PhD

Trilogy Writing & Consulting, Germany

Senior Partner/President

Digitizing Decision Documentation at the FDA – Are We There Yet?

Eileen E. Navarro Almario, MD, MS, FACP

FDA, United States

Lead Physician